R01 CA192402/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2015	2
2016	6
2017	3
2018	1
2019	3
2024	0

1

Missteps in Current Estimates of Cancer Overdiagnosis.

Lee CI, Etzioni R. Lee CI, et al. Acad Radiol. 2017 Feb;24(2):226-229. doi: 10.1016/j.acra.2016.05.020. Epub 2016 Nov 25. Acad Radiol. 2017. PMID: 27894707 Free PMC article. Review.

2

Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.

Etzioni R, Gulati R. Etzioni R, et al. J Natl Cancer Inst. 2015 Nov 18;108(3):djv345. doi: 10.1093/jnci/djv345. Print 2016 Mar. J Natl Cancer Inst. 2015. PMID: 26582245 Free PMC article. Review.

3

A Matched Cohort Analysis of Prostate Cancer Screening in Younger Men in Sweden.

Gulati R, Etzioni R. Gulati R, et al. Eur Urol. 2017 Jan;71(1):53-54. doi: 10.1016/j.eururo.2016.04.006. Epub 2016 Apr 16. Eur Urol. 2017. PMID: 27090976 No abstract available.

4

Active Surveillance for Ductal Carcinoma in Situ: Shining Light Into the Modeling Abyss.

Etzioni R, Gulati R. Etzioni R, et al. J Natl Cancer Inst. 2015 Dec 17;108(5):djv378. doi: 10.1093/jnci/djv378. Print 2016 May. J Natl Cancer Inst. 2015. PMID: 26683406 No abstract available.

5

Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication.

Gulati R, Psutka SP, Etzioni R. Gulati R, et al. J Urol. 2019 Nov;202(5):936-943. doi: 10.1097/JU.0000000000000346. Epub 2019 Oct 9. J Urol. 2019. PMID: 31112106 Free PMC article.

6

The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.

Birnbaum J, Gadi VK, Markowitz E, Etzioni R. Birnbaum J, et al. Ann Intern Med. 2016 Feb 16;164(4):236-43. doi: 10.7326/M15-0754. Epub 2016 Jan 12. Ann Intern Med. 2016. PMID: 26756332 Free PMC article.

7

Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.

Gulati R, Feuer EJ, Etzioni R. Gulati R, et al. Am J Epidemiol. 2016 Jul 15;184(2):140-7. doi: 10.1093/aje/kwv342. Epub 2016 Jun 29. Am J Epidemiol. 2016. PMID: 27358266 Free PMC article.

8

Estimating the frequency of indolent breast cancer in screening trials.

Shen Y, Dong W, Gulati R, Ryser MD, Etzioni R. Shen Y, et al. Stat Methods Med Res. 2019 Apr;28(4):1261-1271. doi: 10.1177/0962280217754232. Epub 2018 Feb 5. Stat Methods Med Res. 2019. PMID: 29402176 Free PMC article.

9

Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials.

Ryser MD, Gulati R, Eisenberg MC, Shen Y, Hwang ES, Etzioni RB. Ryser MD, et al. Am J Epidemiol. 2019 Jan 1;188(1):197-205. doi: 10.1093/aje/kwy214. Am J Epidemiol. 2019. PMID: 30325415 Free PMC article.

10

Both a stage shift and changes in stage-specific survival have contributed to reductions in breast cancer mortality.

Duffy SW, Etzioni R, Sasieni P. Duffy SW, et al. Evid Based Med. 2017 Apr;22(2):76. doi: 10.1136/ebmed-2016-110632. Epub 2017 Feb 22. Evid Based Med. 2017. PMID: 28228386 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year